Group items tagged

Pharmaceutical and Biotech companies are often involved with litigation concerning either contractual issue with business partners or patent and trademark infringement. Adversaries often request documentation they may find relevant to their cases. This has driven the adoption of formal information retention programs and eDiscovery practices. Email is no longer the most commonly requested records companies must produce. Both structured and unstructured information sources have recently outranked email. There is also a notable rise in demands for access to social media and mobile phone text messages. eDiscovery costs can be enormous requiring large investments in IT resources to retrieve requested records and the hiring of specialists to sort through the archives, not to mention advice and guidance from legal consultants.

By knowing how genes pass on instructions and why the instructions sometimes become garbled, eventually it may be possible to introduce new genetic information into cells and correct defects…One day, scientists believe, genetic, genetic engineering may provide a cure for gene-influenced cancers and other diseases as well.